Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Allergy
Published in: Clinical and Translational Allergy 1/2017

Open Access 01-12-2017 | Review

Quality indicators for the acute and long-term management of anaphylaxis: a systematic review

Authors: Sangeeta Dhami, Aadam Sheikh, Antonella Muraro, Graham Roberts, Susanne Halken, Monserat Fernandez Rivas, Margitta Worm, Aziz Sheikh

Published in: Clinical and Translational Allergy | Issue 1/2017

Login to get access

Abstract

Background

The quality of acute and long-term anaphylaxis management is variable and this contributes to the poor outcomes experienced by many patients. Clinical practice guidelines have the potential to improve outcomes, but implementing guideline recommendations in routine practice is challenging. Quality indicators have the potential to support guideline implementation efforts.

Objective

To identify quality indicators to support the acute and long-term management of anaphylaxis.

Methods

We conducted a systematic review of the literature that involved searching Medline, EMBASE and CINAHL databases for peer-reviewed published literature for the period 1 January 2005–31 December 2015. Additionally we searched Google for grey and unpublished literature. The identified indicators were descriptively summarized against the most recent international anaphylaxis guidelines (i.e. those produced by the European Academy of Allergy and Clinical Immunology) and critically evaluated using the Agency for Healthcare Research and Quality’s criteria for indicator development.

Results

Our searches revealed 830 publications, from which we identified five sources for 54 indicators addressing both acute (n = 27) and long-term (n = 27) management of anaphylaxis. The majority of indicators were developed through expert consensus with relatively few of these having been formally piloted or tested to demonstrate that they could discriminate between variations in practice and/or that they were sensitive to change.

Conclusions

There is a need for a comprehensive set of quality indicators for anaphylaxis management. We have however identified some indicators for the acute and long-term management of anaphylaxis that could with relatively little additional work support efforts to translate guideline recommendations into clinical care.
Appendix
Available only for authorised users
Literature
1.
Johansson SGO, Bieber T, Dahl R, Friedmann PS, Lanier B, Lockey RF, et al. A revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of World Allergy Organization. J Allergy Clin Immunol. 2004;113:832–6.CrossRefPubMed
2.
Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007;62(8):857–71.CrossRefPubMed
3.
4.
5.
Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026–45. doi:10.​1111/​all.​12437.CrossRefPubMed
6.
Simons E, Ardusso L, Beatrice Bilò M, El-Gamal Y, Ledford D, Ring J, et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2010;4(2):13–37.CrossRef
7.
Vale S, Smith J, Said M, Mullins R, Loh R. ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update. J Paediatr Child Health. 2015. doi:10.​1111/​jpc.​12962.PubMed
8.
9.
10.
11.
12.
Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernández Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014. doi:10.​1111/​all.​12437.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Metadata
Title
Quality indicators for the acute and long-term management of anaphylaxis: a systematic review
Authors
Sangeeta Dhami
Aadam Sheikh
Antonella Muraro
Graham Roberts
Susanne Halken
Monserat Fernandez Rivas
Margitta Worm
Aziz Sheikh
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Clinical and Translational Allergy / Issue 1/2017
Electronic ISSN: 2045-7022
DOI
https://doi.org/10.1186/s13601-017-0151-1

Other articles of this Issue 1/2017

Clinical and Translational Allergy 1/2017 Go to the issue

Review

Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews

Review

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Brief communication

National clinical practice guidelines for food allergy and anaphylaxis: an international assessment

Review

Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP—an international interpretation of the MAP (Milk Allergy in Primary Care) guideline

Erratum

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

Editorial

An interpretation of the new international MAP guideline for the management of Milk Allergy in Primary Care